Experimental investigations on immunodepressive properties of carcinogenic substances in male Sprague-Dawley rats.
D000477:Alkylating Agents / Q000494:pharmacology; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D000917:Antibody Formation / Q000187:drug effects; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002273:Carcinogens / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000494:pharmacology; D005472:Fluorouracil / Q000494:pharmacology; D007165:Immunosuppression Therapy; D008297:Male; D015122:Mercaptopurine / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D009374:Neoplasms, Experimental / Q000139:chemically induced* / Q000276:immunology; D009602:Nitrosamines / Q000494:pharmacology; D009603:Nitroso Compounds / Q000494:pharmacology; D051381:Rats; D013154:Spleen / Q000187:drug effects / Q000276:immunology
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D002273:Carcinogens; D009602:Nitrosamines; D009603:Nitroso Compounds; D003520:Cyclophosphamide; D015122:Mercaptopurine; D005472:Fluorouracil; D008727:Methotrexate